Atlas Trials

A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B

Clinical trial NCT03357822 · UNKNOWN

Trial details

NCT number
NCT03357822
Sponsor
Tongji Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2018-01-25
Primary completion
2022-01-25
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.